| CD38-NAD+ axis regulates immunotherapeutic anti-tumor T cell response S Chatterjee, A Daenthanasanmak, P Chakraborty, MW Wyatt, P Dhar, ... Cell metabolism 27 (1), 85-100. e8, 2018 | 229 | 2018 |
| Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation HD Nguyen, S Chatterjee, KMK Haarberg, Y Wu, D Bastian, J Heinrichs, ... The Journal of clinical investigation 126 (4), 1337-1352, 2016 | 128 | 2016 |
| Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation BC Betts, D Bastian, S Iamsawat, H Nguyen, JL Heinrichs, Y Wu, ... Proceedings of the National Academy of Sciences 115 (7), 1582-1587, 2018 | 74 | 2018 |
| Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice A Daenthanasanmak, S Iamsawat, P Chakraborty, HD Nguyen, D Bastian, ... Blood, The Journal of the American Society of Hematology 133 (3), 266-279, 2019 | 66 | 2019 |
| CD8+ Tregs promote GVHD prevention and overcome the impaired GVL effect mediated by CD4+ Tregs in mice J Heinrichs, J Li, H Nguyen, Y Wu, D Bastian, A Daethanasanmak, ... Oncoimmunology 5 (6), e1146842, 2016 | 63 | 2016 |
| Ceramide synthesis regulates T cell activity and GVHD development MH Sofi, J Heinrichs, M Dany, H Nguyen, M Dai, D Bastian, S Schutt, ... JCI insight 2 (10), 2017 | 56 | 2017 |
| Targeting PIM kinase with PD1 inhibition improves immunotherapeutic antitumor T-cell response S Chatterjee, P Chakraborty, A Daenthanasanmak, S Iamsawat, ... Clinical cancer research 25 (3), 1036-1049, 2019 | 51 | 2019 |
| Dendritic cell–mediated immune humanization of mice: implications for allogeneic and xenogeneic stem cell transplantation G Salguero, A Daenthanasanmak, C Münz, A Raykova, CA Guzmán, ... The Journal of Immunology 192 (10), 4636-4647, 2014 | 51 | 2014 |
| Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease MH Sofi, Y Wu, SD Schutt, M Dai, A Daenthanasanmak, JH Voss, ... The Journal of Clinical Investigation 129 (7), 2760-2774, 2019 | 38 | 2019 |
| PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity A Daenthanasanmak, Y Wu, S Iamsawat, HD Nguyen, D Bastian, ... The Journal of clinical investigation 128 (7), 2787-2801, 2018 | 32 | 2018 |
| Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo A Daenthanasanmak, G Salguero, S Borchers, C Figueiredo, R Jacobs, ... Vaccine 30 (34), 5118-5131, 2012 | 31 | 2012 |
| Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma T Ishio, S Kumar, J Shimono, A Daenthanasanmak, S Dubois, Y Lin, ... Blood, The Journal of the American Society of Hematology 139 (10), 1541-1556, 2022 | 30 | 2022 |
| Stabilization of Foxp3 by targeting JAK2 enhances efficacy of CD8 induced regulatory T cells in the prevention of graft-versus-host disease S Iamsawat, A Daenthanasanmak, JH Voss, H Nguyen, D Bastian, C Liu, ... The Journal of Immunology 201 (9), 2812-2823, 2018 | 27 | 2018 |
| Engineered dendritic cells from cord blood and adult blood accelerate effector T cell immune reconstitution against HCMV A Daenthanasanmak, G Salguero, BS Sundarasetty, C Waskow, ... Molecular Therapy Methods & Clinical Development 2, 2015 | 27 | 2015 |
| Inducible T-cell co-stimulator impacts chronic graft-versus-host disease by regulating both pathogenic and regulatory T cells M Zhang, Y Wu, D Bastian, S Iamsawat, J Chang, A Daenthanasanmak, ... Frontiers in Immunology 9, 1461, 2018 | 26 | 2018 |
| Complement C3a and C5a receptors promote GVHD by suppressing mitophagy in recipient dendritic cells H Nguyen, S Kuril, D Bastian, J Kim, M Zhang, SG Vaena, M Dany, M Dai, ... JCI insight 3 (24), 2018 | 23 | 2018 |
| Vitamin C stabilizes CD8+ iTregs and enhances their therapeutic potential in controlling murine GVHD and leukemia relapse S Iamsawat, L Tian, A Daenthanasanmak, Y Wu, HD Nguyen, D Bastian, ... Blood advances 3 (24), 4187-4201, 2019 | 20 | 2019 |
| A very long-acting IL-15: implications for the immunotherapy of cancer JA Hangasky, W Chen, SP Dubois, A Daenthanasanmak, JR Müller, ... Journal for Immunotherapy of Cancer 10 (1), 2022 | 16 | 2022 |
| Generation of lentivirus-induced dendritic cells under GMP-compliant conditions for adaptive immune reconstitution against cytomegalovirus after stem cell transplantation BS Sundarasetty, S Kloess, O Oberschmidt, S Naundorf, K Kuehlcke, ... Journal of translational medicine 13, 1-19, 2015 | 16 | 2015 |
| Enhanced efficacy of JAK1 inhibitor with mTORC1/C2 targeting in smoldering/chronic adult T cell leukemia A Daenthanasanmak, Y Lin, M Zhang, BR Bryant, MN Petrus, RN Bamford, ... Translational oncology 14 (1), 100913, 2021 | 8 | 2021 |
